At CRK Clinical Research Key, we offer expert guidance in Biosimilar and generic development in Kenya, ensuring cost-effective and efficient pathways to high-quality, safe, and effective clinical studies at every stage.

Comprehensive Biosimilar & Generics Development Support

Suppose you aim to develop cost-effective alternatives to existing biological drugs (Biosimilars) or small-molecule drugs (Generics). In that case, CRK provides comprehensive support and a wide range of expert biosimilar and generic solutions. Our team will craft a tailored strategy to mitigate risks and ensure a smooth, cost-efficient clinical development process for your product.

Expertise in Global Biosimilar Clinical Plans

We specialize in designing and executing global biosimilar clinical strategies, ensuring timely delivery and high-quality results. Our key services include:


Gap analysis for comparative analytical similarity assessments
Drug development consulting
Strategic advisory for biosimilar & generic development

Enhancing Efficiency & Reducing Risk

We provide:

  • Clinical pharmacology expertise
  • Bioanalytical laboratory services
  • Operational support for product authorization

All our solutions are designed to streamline processes, enhance efficiency, reduce costs, and minimize risks in biosimilar and generic development.

Key Services

Biosimilar and Generics Development in Kenya

Contact Us

Contact us today to explore how our expertise can support your biosimilar and generic development in Kenya.
Contact Us